HDAC6 and breast cancer: In MCF-7 breast cancer cells, CBP-mediated acetylation and its effect on survivin deacetylation suggest that HDAC6’s subcellular localisation can be altered through interactions with acetyltransferase proteins and by regulating its binding with other protein partners.